Oncology & Cancer

How loss of single gene fuels deadly childhood brain cancer

Atypical teratoid rhabdoid tumors (ATRT) are a rare, fast-growing form of brain cancer that usually strikes children three years and younger, though they can occur in older children and adults. There are multiple treatments, ...

Oncology & Cancer

New nanosystem enhances treatment for melanoma in animal models

Researchers at Tel Aviv University, led by Prof. Ronit Satchi-Fainaro of TAU's Department of Physiology and Pharmacology at the Sackler School of Medicine, have developed an innovative nanotechnological drug delivery system ...

Immunology

Brain's immune cells promising cellular target for therapeutics

Inspired by the need for new and better therapies for neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease, Rutgers University researchers are exploring the link between uncontrolled inflammation ...

Oncology & Cancer

The behavior of therapeutic antibodies in immunotherapy

Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of cancerous white blood cells. However, in the more than 20 years since ...

Medical research

Fat cell hormone boosts potential of stem cell therapy

Mesenchymal stem cells (MSCs) have the potential to differentiate into a range of different cell types, including bone, fat and muscle cells. But it's their ability to stimulate the repair of damaged tissue that has captured ...

Diseases, Conditions, Syndromes

Research into drugs and vaccines to combat COVID-19

As the world anxiously awaits a remedy for the novel coronavirus, ETH Zurich is also involved in the search for active substances and vaccines. This overview sets out the therapeutic approaches pursued by ETH researchers.

page 20 from 40